Hikma Could Consider Exit Strategy For Generics Business
Also Provides Update On CEO Search As Recruitment Process Continues
• By David Wallace
Hikma could consider exiting the generics business – but admits the timing might not be right to extract maximum value from the division • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
